NFKB1 and Alzheimer disease: TanIIA treatment can inhibit the proliferation of astrocytes, reduce the level of NF-κB, and increase NeuN, Nissl bodies and inhibitor of NF-κB (IκB) in an AD rat model, all of which exert anti-inflammatory and neuroprotective effects (Li et al., 2015).